|Day Low/High||23.54 / 23.82|
|52 Wk Low/High||15.67 / 24.79|
Demand is quite healthy and markets are not going into the abyss, Cramer says.
Pay attention to what companies are doing to improve themselves, not the hand-wringing from fund managers about Fed intervention.
Wells Fargo CEO John Stumpf apologizes to the bank's customers and Cramer says Boston Scientific is a stock to buy right now.
But Cramer continues to raise cash for his charitable trust so he can pounce on quality stocks as the market takes them lower.
In the last year, shares of Boston Scientific are up almost 50%. Boston Scientific is putting the problems of the past behind it and has a bright future.
Potential targets of the medical device and diagnostics giant might request stricter parameters when structuring a deal, company followers say.
These stocks have both short-term gain catalysts and longer-term growth potential.
Approval Grants MR-Conditional Labeling to All EMBLEM S-ICD Systems, Expands ImageReady™ Portfolio
Stocks with insider trader activity include SXC, BSX and KFS
Jefferies upped its price target to $24 on Boston Scientific (BSX) stock this morning.
TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,300 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: BCC, CYS, DISH, ESRT, FCFS, FSI, GIMO, INVA, KSU, NATI, ORC, RMCF, TREE, WLDN, WMGI, WRE, ZION Downgrades: ACIW, ACOR, BSX, DLR, FI, HTH, IP, OVBC, SBBX Initiations: GNRT, MB, PUB Read on to get TheStreet Quant Ratings' detailed report:
Boston Scientific (BSX) stock is advancing this morning after the company posted better-than-expected fiscal 2016 second quarter revenue before today's opening bell.
Trade-Ideas LLC identified Boston Scientific (BSX) as an unusual social activity candidate
Trade-Ideas LLC identified Boston Scientific (BSX) as a post-market leader candidate
TheStreet highlights 3 stocks pushing the health care sector lower today.
Addition of Leading Radiofrequency Ablation Company Expands Therapeutic Options for Patients with Chronic Pain
TheStreet highlights 3 stocks pushing the health services industry lower today.
Can medical technology stocks continue their momentum higher in the second half of the year? Investors say yes, but technical analysis says not necessarily.
Listen to what the companies are actually telling you. Then assess what that might mean for the future, Cramer says.
Engaged Capital agitated against the cardiac medical device maker's buy of an Israeli company and pushed for a new board member that once led the acquirer's M&A efforts.
Studies show that treatment is less costly and has lower hospital re-admissions
There is so much buying power in so many new areas.
Wall Street made its best effort to extend a three-day winning streak into a fourth session on Thursday but last-minute moves toward the flatline weren't enough.
Stocks extend their decline by early afternoon Thursday as investors engage in profit-taking after three days of gains.
Boston Scientific (BSX) stock is climbing this afternoon after the company announced a restructuring program.